Skip to content

Investigation of visual and auditory basic symptoms in patients with schizophrenia-spectrum-disorders

Investigation of visual and auditory basic symptoms in patients with schizophrenia-spectrum-disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039140
Enrollment
600
Registered
2026-01-29
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia-spectrum disorder (F20.x und F25.x), ARMS, healthy controls

Interventions

Group 1: Investigation of basic symptoms in people with schizophrenia, in individuals wit at-risk mental state (ARMS), and healthy participants, involving: - assessment using questionnaires (one-time

Sponsors

Klinik für Psychiatrie, Psychosomatik und Psychotherapie, Universitätsklinikum Frankfurt, Goethe Universität
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Capacity for informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria for healthy controls - Current or past neurological disorder (e.g., migraine or epilepsy), including traumatic brain injury - Current or past severe somatic illness with a potential impact on cognitive performance, including oncological and autoimmune diseases - Current or past ophthalmological disorder, including color blindness, red–green color vision deficiency, strabismus, and pronounced astigmatism - Current or past audiological disorder, including hearing loss, deafness, and tinnitus - Presence of a mental disorder - Family history of neuropsychiatric disorders - Use of medication - Regular use of hallucinogenic drugs and alcohol within the past 3 months Exclusion criteria for patients - Current or past neurological disorder (e.g., migraine or epilepsy), including traumatic brain injury - Current or past severe somatic illness, including oncological and autoimmune diseases - Current or past ophthalmological disorder, including color blindness and red–green color vision deficiency - Current or past audiological disorder, including hearing loss, deafness, and tinnitus - Regular use of hallucinogenic drugs and alcohol within the past 3 months

Design outcomes

Primary

MeasureTime frame
- Correlation between the severity and frequency of basic symptoms and positive symptoms - Correlation between the severity and frequency of basic symptoms and negative symptoms - Correlation between the severity and frequency of basic symptoms and cognitive impairments - Correlation between the severity and frequency of basic symptoms and participants’ level of functioning

Secondary

MeasureTime frame
- Correlation between the severity and frequency of basic symptoms and participants’ level of functioning - Correlation between the severity and frequency of basic symptoms and PRS-Resilience and PRS-Risk, respectively

Countries

Germany

Contacts

Public ContactRobert Bittner

Klinik für Psychiatrie, Psychosomatik und Psychotherapie, Universitätsklinikum Frankfurt, Goethe Universität

robert.bittner@med.uni-frankfurt.de069630186504

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026